Skip to main content
Table of Contents
Print

Can Cannabis Help Prevent Depressive Relapse in Patients? 

Author: Dr. Clarissa Morton, PharmD

The potential role of cannabis and depressive relapse prevention is an area of growing interest in mental health care. Relapse is common in depression , with many patients experiencing recurring episodes even after initial recovery. Some early reports suggest cannabis, particularly CBD, may support ongoing stability by easing anxiety, improving sleep, and reducing stress triggers that often contribute to relapse. 

However, evidence is still limited. While some patients find cannabis beneficial for mood stabilisation, others may experience negative effects, particularly with long-term or high-THC use. This makes careful monitoring essential. 

Cannabis And Long-Term Care 

Research into cannabis and depressive relapse focuses on whether cannabinoids could play a role in maintenance strategies designed to reduce recurrence. 

Recurrence Prevention 

Some studies suggest cannabis might aid recurrence prevention by helping regulate stress responses and supporting emotional balance. Still, these findings remain preliminary. 

Mood Stabilisation 

CBD has been linked to potential mood stabilisation, offering calmer emotional regulation and reducing the severity of stress-related triggers. In contrast, THC shows more variable outcomes. 

Maintenance Therapy 

Cannabis is sometimes discussed as a form of maintenance therapy, helping patients manage lingering symptoms between depressive episodes. Yet, clinical trials are needed to confirm its long-term safety and effectiveness. 

In summary, while early findings on cannabis and depressive relapse are promising, they are far from conclusive. Patients should approach this area cautiously and under professional guidance. 

For individuals interested in whether cannabis could support relapse prevention, providers like LeafEase can offer personalised consultations to explore safe and tailored options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories